Background Bullous pemphigoid (BP) is the most common autoimmune subepidermal
bullous disease of the skin. First-line treatment of systemic corticosteroids may cause …

Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease
in Western countries, and typically affects the elderly. BP is immunologically characterized …

This guideline has been initiated by the task force Autoimmune Blistering Diseases of the
European Academy of Dermatology and Venereology, including physicians from all relevant …

Background Bullous pemphigoid (BP) is an autoimmune blistering disorder that
predominantly affects the elderly. As the main treatment for BP, systemic corticosteroids are …

Bullous pemphigoid (BP) is the most common autoimmune bullous disorder which is
characterized by autoantibodies against hemidesmosomal proteins of the skin and mucous …

This meta-analysis examined the efficacy of different dosing regimens containing rituximab
(RTX) in treating pemphigus. The analysis included 578 patients with pemphigus from 30 …

Mucous membrane pemphigoid (MMP) is a heterogeneous group of chronic, autoimmune
subepithelial blistering diseases that predominantly involves the mucous membranes and …

The present S2K guidelines are an update of the most recent edition of the German
guidelines from 2015 [1, 2]. The complete guidelines (including methodology) are available …

The overall objective of the guideline is to provide up-to-date, evidence-based
recommendations for the management of bullous pemphigoid (BP). The document aims to …

Many ulcerative or vesiculobullous disease of the mouth have a similar clinical appearance.
The oral mucosa is thin, and even slight trauma leads to rupture of vesicles and bullae …